Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1996 Jul;61(1):4–16. doi: 10.1136/jnnp.61.1.4

How far are we in understanding the cause of Parkinson's disease?

Y Ben-Shlomo 1
PMCID: PMC486447  PMID: 8676157

Full text

PDF
4

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aquilonius S. M., Hartvig P. A Swedish county with unexpectedly high utilization of anti-parkinsonian drugs. Acta Neurol Scand. 1986 Nov;74(5):379–382. doi: 10.1111/j.1600-0404.1986.tb03529.x. [DOI] [PubMed] [Google Scholar]
  2. Armstrong M., Daly A. K., Cholerton S., Bateman D. N., Idle J. R. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet. 1992 Apr 25;339(8800):1017–1018. doi: 10.1016/0140-6736(92)90537-d. [DOI] [PubMed] [Google Scholar]
  3. BARBEAU A., JOLY J. G. [Parkinsonism and cancer]. Union Med Can. 1963 Feb;92:169–174. [PubMed] [Google Scholar]
  4. Baumann R. J., Jameson H. D., McKean H. E., Haack D. G., Weisberg L. M. Cigarette smoking and Parkinson disease: 1. Comparison of cases with matched neighbors. Neurology. 1980 Aug;30(8):839–843. doi: 10.1212/wnl.30.8.839. [DOI] [PubMed] [Google Scholar]
  5. Ben-Shlomo Y., Finnan F., Allwright S., Davey Smith G. The epidemiology of Parkinson's disease in the Republic of Ireland: observations from routine data sources. Ir Med J. 1993 Nov-Dec;86(6):190-1, 194. [PubMed] [Google Scholar]
  6. Ben-Shlomo Y., Marmot M. G. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? J Neurol Neurosurg Psychiatry. 1995 Mar;58(3):293–299. doi: 10.1136/jnnp.58.3.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ben-Shlomo Y., Sieradzan K. Idiopathic Parkinson's disease: epidemiology, diagnosis and management. Br J Gen Pract. 1995 May;45(394):261–268. [PMC free article] [PubMed] [Google Scholar]
  8. Ben-Shlomo Y. Smoking and neurogenerative diseases. Lancet. 1993 Nov 13;342(8881):1239–1239. [PubMed] [Google Scholar]
  9. Ben-Shlomo Y., Wenning G. Incidental Lewy body disease. Lancet. 1994 Nov 26;344(8935):1503–1503. doi: 10.1016/s0140-6736(94)90319-0. [DOI] [PubMed] [Google Scholar]
  10. Bharucha N. E., Bharucha E. P., Bharucha A. E., Bhise A. V., Schoenberg B. S. Prevalence of Parkinson's disease in the Parsi community of Bombay, India. Arch Neurol. 1988 Dec;45(12):1321–1323. doi: 10.1001/archneur.1988.00520360039008. [DOI] [PubMed] [Google Scholar]
  11. Bharucha N. E., Stokes L., Schoenberg B. S., Ward C., Ince S., Nutt J. G., Eldridge R., Calne D. B., Mantel N., Duvoisin R. A case-control study of twin pairs discordant for Parkinson's disease: a search for environmental risk factors. Neurology. 1986 Feb;36(2):284–288. doi: 10.1212/wnl.36.2.284. [DOI] [PubMed] [Google Scholar]
  12. Blair A., Zahm S. H. Patterns of pesticide use among farmers: implications for epidemiologic research. Epidemiology. 1993 Jan;4(1):55–62. doi: 10.1097/00001648-199301000-00011. [DOI] [PubMed] [Google Scholar]
  13. Blazer D. G., Landerman L. R., Fillenbaum G., Horner R. Health services access and use among older adults in North Carolina: urban vs rural residents. Am J Public Health. 1995 Oct;85(10):1384–1390. doi: 10.2105/ajph.85.10.1384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Brown E. L., Knox E. G. Epidemiological approach to Parkinson's disease. Lancet. 1972 May 6;1(7758):974–976. doi: 10.1016/s0140-6736(72)91152-x. [DOI] [PubMed] [Google Scholar]
  15. Butterfield P. G., Valanis B. G., Spencer P. S., Lindeman C. A., Nutt J. G. Environmental antecedents of young-onset Parkinson's disease. Neurology. 1993 Jun;43(6):1150–1158. doi: 10.1212/wnl.43.6.1150. [DOI] [PubMed] [Google Scholar]
  16. Calne D. B., Langston J. W. Aetiology of Parkinson's disease. Lancet. 1983 Dec 24;2(8365-66):1457–1459. doi: 10.1016/s0140-6736(83)90802-4. [DOI] [PubMed] [Google Scholar]
  17. Clarke C. E. Does levodopa therapy delay death in Parkinson's disease? A review of the evidence. Mov Disord. 1995 May;10(3):250–256. doi: 10.1002/mds.870100303. [DOI] [PubMed] [Google Scholar]
  18. Clarke C. E. Mortality from Parkinson's disease in England and Wales 1921-89. J Neurol Neurosurg Psychiatry. 1993 Jun;56(6):690–693. doi: 10.1136/jnnp.56.6.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Cummings J. L. Depression and Parkinson's disease: a review. Am J Psychiatry. 1992 Apr;149(4):443–454. doi: 10.1176/ajp.149.4.443. [DOI] [PubMed] [Google Scholar]
  20. Di Monte D., Sandy M. S., Blank L., Smith M. T. Fructose prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced ATP depletion and toxicity in isolated hepatocytes. Biochem Biophys Res Commun. 1988 Jun 16;153(2):734–740. doi: 10.1016/s0006-291x(88)81156-2. [DOI] [PubMed] [Google Scholar]
  21. Doll R., Peto R., Wheatley K., Gray R., Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ. 1994 Oct 8;309(6959):901–911. doi: 10.1136/bmj.309.6959.901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Dwyer J. T., Gardner J., Halvorsen K., Krall E. A., Cohen A., Valadian I. Memory of food intake in the distant past. Am J Epidemiol. 1989 Nov;130(5):1033–1046. doi: 10.1093/oxfordjournals.aje.a115404. [DOI] [PubMed] [Google Scholar]
  23. Eatough V. M., Kempster P. A., Stern G. M., Lees A. J. Premorbid personality and idiopathic Parkinson's disease. Adv Neurol. 1990;53:335–337. [PubMed] [Google Scholar]
  24. Ebmeier K. P., Calder S. A., Crawford J. R., Stewart L., Besson J. A., Mutch W. J. Parkinson's disease in Aberdeen: survival after 3.5 years. Acta Neurol Scand. 1990 Apr;81(4):294–299. doi: 10.1111/j.1600-0404.1990.tb01558.x. [DOI] [PubMed] [Google Scholar]
  25. Ebmeier K. P., Mutch W. J., Calder S. A., Crawford J. R., Stewart L., Besson J. O. Does idiopathic parkinsonism in Aberdeen follow intrauterine influenza? J Neurol Neurosurg Psychiatry. 1989 Jul;52(7):911–913. doi: 10.1136/jnnp.52.7.911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Eldridge R., Ince S. E. The low concordance rate for Parkinson's disease in twins: a possible explanation. Neurology. 1984 Oct;34(10):1354–1356. doi: 10.1212/wnl.34.10.1354. [DOI] [PubMed] [Google Scholar]
  27. Elizan T. S., Madden D. L., Noble G. R., Herrmann K. L., Gardner J., Schwartz J., Smith H., Jr, Sever J. L., Yahr M. D. Viral antibodies in serum and CSF of Parkinsonian patients and controls. Arch Neurol. 1979 Sep;36(9):529–534. doi: 10.1001/archneur.1979.00500450023002. [DOI] [PubMed] [Google Scholar]
  28. Factor S. A., Sanchez-Ramos J., Weiner W. J. Trauma as an etiology of parkinsonism: a historical review of the concept. Mov Disord. 1988;3(1):30–36. doi: 10.1002/mds.870030105. [DOI] [PubMed] [Google Scholar]
  29. Forgays D. G., Bonaiuto P., Wrzesniewski K., Forgays D. K. Personality and cigarette smoking in Italy, Poland, and the United States. Int J Addict. 1993 Apr;28(5):399–413. doi: 10.3109/10826089309039638. [DOI] [PubMed] [Google Scholar]
  30. GOLDBERG I. D., KURLAND L. T. Mortality in 33 countries from diseases of the nervous system. World Neurol. 1962 Jun;3:444–465. [PubMed] [Google Scholar]
  31. Gibb W. R., Lees A. J. The progression of idiopathic Parkinson's disease is not explained by age-related changes. Clinical and pathological comparisons with post-encephalitic parkinsonian syndrome. Acta Neuropathol. 1987;73(2):195–201. doi: 10.1007/BF00693789. [DOI] [PubMed] [Google Scholar]
  32. Godwin-Austen R. B., Lee P. N., Marmot M. G., Stern G. M. Smoking and Parkinson's disease. J Neurol Neurosurg Psychiatry. 1982 Jul;45(7):577–581. doi: 10.1136/jnnp.45.7.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Godwin-Austen R. B., Lee P. N., Marmot M. G., Stern G. M. Smoking and Parkinson's disease. J Neurol Neurosurg Psychiatry. 1982 Jul;45(7):577–581. doi: 10.1136/jnnp.45.7.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Golbe L. I., Cody R. A., Duvoisin R. C. Smoking and Parkinson's disease. Search for a dose-response relationship. Arch Neurol. 1986 Aug;43(8):774–778. doi: 10.1001/archneur.1986.00520080022014. [DOI] [PubMed] [Google Scholar]
  35. Golbe L. I., Farrell T. M., Davis P. H. Case-control study of early life dietary factors in Parkinson's disease. Arch Neurol. 1988 Dec;45(12):1350–1353. doi: 10.1001/archneur.1988.00520360068014. [DOI] [PubMed] [Google Scholar]
  36. Golbe L. I., Farrell T. M., Davis P. H. Follow-up study of early-life protective and risk factors in Parkinson's disease. Mov Disord. 1990;5(1):66–70. doi: 10.1002/mds.870050116. [DOI] [PubMed] [Google Scholar]
  37. Granieri E., Carreras M., Casetta I., Govoni V., Tola M. R., Paolino E., Monetti V. C., De Bastiani P. Parkinson's disease in Ferrara, Italy, 1967 through 1987. Arch Neurol. 1991 Aug;48(8):854–857. doi: 10.1001/archneur.1991.00530200096026. [DOI] [PubMed] [Google Scholar]
  38. Gresham L. S., Molgaard C. A., Smith R. A. Induction of cytochrome P-450 enzymes via tobacco smoke: a potential mechanism for developing resistance to environmental toxins as related to parkinsonism and other neurologic diseases. Neuroepidemiology. 1993;12(2):114–116. doi: 10.1159/000110309. [DOI] [PubMed] [Google Scholar]
  39. Haack D. G., Baumann R. J., McKean H. E., Jameson H. D., Turbek J. A. Nicotine exposure and Parkinson disease. Am J Epidemiol. 1981 Aug;114(2):191–200. doi: 10.1093/oxfordjournals.aje.a113182. [DOI] [PubMed] [Google Scholar]
  40. Hammond E. C. Smoking in relation to the death rates of one million men and women. Natl Cancer Inst Monogr. 1966 Jan;19:127–204. [PubMed] [Google Scholar]
  41. Harada H., Nishikawa S., Takahashi K. Epidemiology of Parkinson's disease in a Japanese city. Arch Neurol. 1983 Mar;40(3):151–154. doi: 10.1001/archneur.1983.04050030045008. [DOI] [PubMed] [Google Scholar]
  42. Hayward R. A., Shapiro M. F., Freeman H. E., Corey C. R. Inequities in health services among insured Americans. Do working-age adults have less access to medical care than the elderly? N Engl J Med. 1988 Jun 9;318(23):1507–1512. doi: 10.1056/NEJM198806093182305. [DOI] [PubMed] [Google Scholar]
  43. Ho S. C., Woo J., Lee C. M. Epidemiologic study of Parkinson's disease in Hong Kong. Neurology. 1989 Oct;39(10):1314–1318. doi: 10.1212/wnl.39.10.1314. [DOI] [PubMed] [Google Scholar]
  44. Hoehn M. M. Parkinson's disease: progression and mortality. Adv Neurol. 1987;45:457–461. [PubMed] [Google Scholar]
  45. Hoehn M. M., Yahr M. D. Parkinsonism: onset, progression and mortality. Neurology. 1967 May;17(5):427–442. doi: 10.1212/wnl.17.5.427. [DOI] [PubMed] [Google Scholar]
  46. Holford T. R. Analysing the temporal effects of age, period and cohort. Stat Methods Med Res. 1992;1(3):317–337. doi: 10.1177/096228029200100306. [DOI] [PubMed] [Google Scholar]
  47. Hughes A. J., Ben-Shlomo Y., Daniel S. E., Lees A. J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 1992 Jun;42(6):1142–1146. doi: 10.1212/wnl.42.6.1142. [DOI] [PubMed] [Google Scholar]
  48. Hughes A. J., Daniel S. E., Kilford L., Lees A. J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181–184. doi: 10.1136/jnnp.55.3.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Imaizumi Y., Kaneko R. Rising mortality from Parkinson's disease in Japan, 1950-1992. Acta Neurol Scand. 1995 Mar;91(3):169–176. doi: 10.1111/j.1600-0404.1995.tb00428.x. [DOI] [PubMed] [Google Scholar]
  50. Jansson B., Jankovic J. Low cancer rates among patients with Parkinson's disease. Ann Neurol. 1985 May;17(5):505–509. doi: 10.1002/ana.410170514. [DOI] [PubMed] [Google Scholar]
  51. Jendroska K., Olasode B. J., Daniel S. E., Elliott L., Ogunniyi A. O., Aghadiuno P. U., Osuntokun B. O., Lees A. J. Incidental Lewy body disease in black Africans. Lancet. 1994 Sep 24;344(8926):882–883. doi: 10.1016/s0140-6736(94)92854-1. [DOI] [PubMed] [Google Scholar]
  52. Jenner P. Oxidative damage in neurodegenerative disease. Lancet. 1994 Sep 17;344(8925):796–798. doi: 10.1016/s0140-6736(94)92347-7. [DOI] [PubMed] [Google Scholar]
  53. Jiménez-Jiménez F. J., Mateo D., Giménez-Roldan S. Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case-control study. Mov Disord. 1992 Oct;7(4):339–344. doi: 10.1002/mds.870070407. [DOI] [PubMed] [Google Scholar]
  54. Jiménez-Jiménez F. J., Mateo D., Giménez-Roldán S. Exposure to well water and pesticides in Parkinson's disease: a case-control study in the Madrid area. Mov Disord. 1992;7(2):149–152. doi: 10.1002/mds.870070209. [DOI] [PubMed] [Google Scholar]
  55. Kahn H. A. The Dorn study of smoking and mortality among U.S. veterans: report on eight and one-half years of observation. Natl Cancer Inst Monogr. 1966 Jan;19:1–125. [PubMed] [Google Scholar]
  56. Kessler I. I. Epidemiologic studies of Parkinson's disease. 3. A community-based survey. Am J Epidemiol. 1972 Oct;96(4):242–254. doi: 10.1093/oxfordjournals.aje.a121455. [DOI] [PubMed] [Google Scholar]
  57. Koller W. C., Langston J. W., Hubble J. P., Irwin I., Zack M., Golbe L., Forno L., Ellenberg J., Kurland L., Ruttenber A. J. Does a long preclinical period occur in Parkinson's disease? Neurology. 1991 May;41(5 Suppl 2):8–13. [PubMed] [Google Scholar]
  58. Koller W. C. When does Parkinson's disease begin? Neurology. 1992 Apr;42(4 Suppl 4):27–48. [PubMed] [Google Scholar]
  59. Koller W. C., Wong G. F., Lang A. Posttraumatic movement disorders: a review. Mov Disord. 1989;4(1):20–36. doi: 10.1002/mds.870040106. [DOI] [PubMed] [Google Scholar]
  60. Koller W., Vetere-Overfield B., Gray C., Alexander C., Chin T., Dolezal J., Hassanein R., Tanner C. Environmental risk factors in Parkinson's disease. Neurology. 1990 Aug;40(8):1218–1221. doi: 10.1212/wnl.40.8.1218. [DOI] [PubMed] [Google Scholar]
  61. Kondo K. Epidemiological evaluations of risk factors in Parkinson's disease. Adv Neurol. 1987;45:289–293. [PubMed] [Google Scholar]
  62. Kurtzke J. F., Murphy F. M. The changing patterns of death rates in parkinsonism. Neurology. 1990 Jan;40(1):42–49. doi: 10.1212/wnl.40.1.42. [DOI] [PubMed] [Google Scholar]
  63. Lang A. E., Marsden C. D., Obeso J. A., Parkes J. D. Alcohol and Parkinson disease. Ann Neurol. 1982 Sep;12(3):254–256. doi: 10.1002/ana.410120307. [DOI] [PubMed] [Google Scholar]
  64. Langston J. W. Predicting Parkinson's disease. Neurology. 1990 Oct;40(10 Suppl 3):suppl 70–76. [PubMed] [Google Scholar]
  65. Larsen J. P. Parkinson's disease as community health problem: study in Norwegian nursing homes. The Norwegian Study Group of Parkinson's Disease in the Elderly. BMJ. 1991 Sep 28;303(6805):741–743. doi: 10.1136/bmj.303.6805.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Li S. C., Schoenberg B. S., Wang C. C., Cheng X. M., Rui D. Y., Bolis C. L., Schoenberg D. G. A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China. Arch Neurol. 1985 Jul;42(7):655–657. doi: 10.1001/archneur.1985.04060070045013. [DOI] [PubMed] [Google Scholar]
  67. Li T. M., Swash M., Alberman E. Morbidity and mortality in motor neuron disease: comparison with multiple sclerosis and Parkinson's disease: age and sex specific rates and cohort analyses. J Neurol Neurosurg Psychiatry. 1985 Apr;48(4):320–327. doi: 10.1136/jnnp.48.4.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Lilienfeld D. E., Chan E., Ehland J., Godbold J., Landrigan P. J., Marsh G., Perl D. P. Two decades of increasing mortality from Parkinson's disease among the US elderly. Arch Neurol. 1990 Jul;47(7):731–734. doi: 10.1001/archneur.1990.00530070019005. [DOI] [PubMed] [Google Scholar]
  69. Manyam B. V. Paralysis agitans and levodopa in "Ayurveda": ancient Indian medical treatise. Mov Disord. 1990;5(1):47–48. doi: 10.1002/mds.870050112. [DOI] [PubMed] [Google Scholar]
  70. Marmot M. G., Adelstein A. M., Bulusu L. Lessons from the study of immigrant mortality. Lancet. 1984 Jun 30;1(8392):1455–1457. doi: 10.1016/s0140-6736(84)91943-3. [DOI] [PubMed] [Google Scholar]
  71. Marmot M. G., Shipley M. J., Rose G. Inequalities in death--specific explanations of a general pattern? Lancet. 1984 May 5;1(8384):1003–1006. doi: 10.1016/s0140-6736(84)92337-7. [DOI] [PubMed] [Google Scholar]
  72. Marttila R. J., Arstila P., Nikoskelainen J., Halonen P. E., Rinne U. K. Viral antibodies in the sera from patients with Parkinson disease. Eur Neurol. 1977;15(1):25–33. doi: 10.1159/000114785. [DOI] [PubMed] [Google Scholar]
  73. Marttila R. J., Rinne U. K. Arteriosclerosis, heredity, and some previous infections in the etiology of Parkinson's disease. A case-control study. Clin Neurol Neurosurg. 1976;79(1):46–56. doi: 10.1016/s0303-8467(76)80005-4. [DOI] [PubMed] [Google Scholar]
  74. Marttila R. J., Rinne U. K. Epidemiology of Parkinson's disease in Finland. Acta Neurol Scand. 1976 Feb;53(2):81–102. doi: 10.1111/j.1600-0404.1976.tb04328.x. [DOI] [PubMed] [Google Scholar]
  75. Marttila R. J., Rinne U. K. Smoking and Parkinson's disease. Acta Neurol Scand. 1980 Nov;62(5):322–325. doi: 10.1111/j.1600-0404.1980.tb03043.x. [DOI] [PubMed] [Google Scholar]
  76. Martyn C. N. Choosing cases and controls in neurological research. J Neurol Neurosurg Psychiatry. 1990 Jun;53(6):453–454. doi: 10.1136/jnnp.53.6.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Martyn C. N., Cruddas M., Compston D. A. Symptomatic Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):167–168. doi: 10.1136/jnnp.56.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Mattock C., Marmot M., Stern G. Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis. J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):753–756. doi: 10.1136/jnnp.51.6.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Mayeux R., Tang M. X., Marder K., Côté L. J., Stern Y. Smoking and Parkinson's disease. Mov Disord. 1994 Mar;9(2):207–212. doi: 10.1002/mds.870090215. [DOI] [PubMed] [Google Scholar]
  80. Morgante L., Rocca W. A., Di Rosa A. E., De Domenico P., Grigoletto F., Meneghini F., Reggio A., Savettieri G., Castiglione M. G., Patti F. Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology. 1992 Oct;42(10):1901–1907. doi: 10.1212/wnl.42.10.1901. [DOI] [PubMed] [Google Scholar]
  81. Mutch W. J., Dingwall-Fordyce I., Downie A. W., Paterson J. G., Roy S. K. Parkinson's disease in a Scottish city. Br Med J (Clin Res Ed) 1986 Feb 22;292(6519):534–536. doi: 10.1136/bmj.292.6519.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Møller H., Mellemkjaer L., McLaughlin J. K., Olsen J. H. Occurrence of different cancers in patients with Parkinson's disease. BMJ. 1995 Jun 10;310(6993):1500–1501. doi: 10.1136/bmj.310.6993.1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Nefzger M. D., Quadfasel F. A., Karl V. C. A retrospective study of smoking in Parkinson's disease. Am J Epidemiol. 1968 Sep;88(2):149–158. doi: 10.1093/oxfordjournals.aje.a120874. [DOI] [PubMed] [Google Scholar]
  84. Ngim C. H., Devathasan G. Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease. Neuroepidemiology. 1989;8(3):128–141. doi: 10.1159/000110175. [DOI] [PubMed] [Google Scholar]
  85. Ohlson C. G., Hogstedt C. Parkinson's disease and occupational exposure to organic solvents, agricultural chemicals and mercury--a case-referent study. Scand J Work Environ Health. 1981 Dec;7(4):252–256. doi: 10.5271/sjweh.2549. [DOI] [PubMed] [Google Scholar]
  86. POSKANZER D. C., SCHWAB R. S. COHORT ANALYSIS OF PARKINSON'S SYNDROME: EVIDENCE FOR A SINGLE ETIOLOGY RELATED TO SUBCLINICAL INFECTION ABOUT 1920. J Chronic Dis. 1963 Sep;16:961–973. doi: 10.1016/0021-9681(63)90098-5. [DOI] [PubMed] [Google Scholar]
  87. Phillips A. N., Smith G. D. How independent are "independent" effects? Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol. 1991;44(11):1223–1231. doi: 10.1016/0895-4356(91)90155-3. [DOI] [PubMed] [Google Scholar]
  88. Plassman B. L., Helms M. J., Welsh K. A., Saunders A. M., Breitner J. C. Smoking, Alzheimer's disease, and confounding with genes. Lancet. 1995 Feb 11;345(8946):387–387. doi: 10.1016/s0140-6736(95)90374-7. [DOI] [PubMed] [Google Scholar]
  89. Poewe W., Karamat E., Kemmler G. W., Gerstenbrand F. The premorbid personality of patients with Parkinson's disease: a comparative study with healthy controls and patients with essential tremor. Adv Neurol. 1990;53:339–342. [PubMed] [Google Scholar]
  90. Rajput A. H., Offord K. P., Beard C. M., Kurland L. T. A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease. Neurology. 1987 Feb;37(2):226–232. doi: 10.1212/wnl.37.2.226. [DOI] [PubMed] [Google Scholar]
  91. Rajput A. H., Offord K. P., Beard C. M., Kurland L. T. A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease. Neurology. 1987 Feb;37(2):226–232. doi: 10.1212/wnl.37.2.226. [DOI] [PubMed] [Google Scholar]
  92. Rajput A. H., Offord K. P., Beard C. M., Kurland L. T. Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol. 1984 Sep;16(3):278–282. doi: 10.1002/ana.410160303. [DOI] [PubMed] [Google Scholar]
  93. Rajput A. H., Uitti R. J., Stern W., Laverty W. Early onset Parkinson's disease in Saskatchewan--environmental considerations for etiology. Can J Neurol Sci. 1986 Nov;13(4):312–316. doi: 10.1017/s0317167100036635. [DOI] [PubMed] [Google Scholar]
  94. Rajput A. H., Uitti R. J., Stern W., Laverty W., O'Donnell K., O'Donnell D., Yuen W. K., Dua A. Geography, drinking water chemistry, pesticides and herbicides and the etiology of Parkinson's disease. Can J Neurol Sci. 1987 Aug;14(3 Suppl):414–418. doi: 10.1017/s0317167100037823. [DOI] [PubMed] [Google Scholar]
  95. Raphael K. Recall bias: a proposal for assessment and control. Int J Epidemiol. 1987 Jun;16(2):167–170. doi: 10.1093/ije/16.2.167. [DOI] [PubMed] [Google Scholar]
  96. Ravenholt R. T., Foege W. H. 1918 influenza, encephalitis lethargica, parkinsonism. Lancet. 1982 Oct 16;2(8303):860–864. doi: 10.1016/s0140-6736(82)90820-0. [DOI] [PubMed] [Google Scholar]
  97. Riggs J. E. Cigarette smoking and Parkinson disease: the illusion of a neuroprotective effect. Clin Neuropharmacol. 1992 Apr;15(2):88–99. doi: 10.1097/00002826-199204000-00002. [DOI] [PubMed] [Google Scholar]
  98. Riggs J. E., Schochet S. S., Jr Rising mortality due to Parkinson's disease and amyotrophic lateral sclerosis: a manifestation of the competitive nature of human mortality. J Clin Epidemiol. 1992 Sep;45(9):1007–1012. doi: 10.1016/0895-4356(92)90116-5. [DOI] [PubMed] [Google Scholar]
  99. Riggs J. E. Smoking and Alzheimer's disease: protective effect or differential survival bias? Lancet. 1993 Sep 25;342(8874):793–794. doi: 10.1016/0140-6736(93)91547-y. [DOI] [PubMed] [Google Scholar]
  100. Ritchie K., Kildea D. Is senile dementia "age-related" or "ageing-related"?--evidence from meta-analysis of dementia prevalence in the oldest old. Lancet. 1995 Oct 7;346(8980):931–934. doi: 10.1016/s0140-6736(95)91556-7. [DOI] [PubMed] [Google Scholar]
  101. Robins A. H. Depression in patients with Parkinsonism. Br J Psychiatry. 1976 Feb;128:141–145. doi: 10.1192/bjp.128.2.141. [DOI] [PubMed] [Google Scholar]
  102. Roelofs G. A. Behavioural state and seizure susceptibility. A study of responses upon electrical stimulation of the basal temporal lobe in cats under different behavioural conditions. Acta Neurol Scand. 1967;43(Suppl):9+–9+. [PubMed] [Google Scholar]
  103. Rybicki B. A., Johnson C. C., Gorell J. M. Demographic differences in referral rates to neurologists of patients with suspected Parkinson's disease: implications for case-control study design. Neuroepidemiology. 1995;14(2):72–81. doi: 10.1159/000109781. [DOI] [PubMed] [Google Scholar]
  104. Sanchez-Ramos J. R., Hefti F., Weiner W. J. Paraquat and Parkinson's disease. Neurology. 1987 Apr;37(4):728–728. doi: 10.1212/wnl.37.4.728. [DOI] [PubMed] [Google Scholar]
  105. Sasco A. J., Paffenbarger R. S., Jr Measles infection and Parkinson's disease. Am J Epidemiol. 1985 Dec;122(6):1017–1031. doi: 10.1093/oxfordjournals.aje.a114183. [DOI] [PubMed] [Google Scholar]
  106. Sasco A. J., Paffenbarger R. S., Jr Smoking and Parkinson's disease. Epidemiology. 1990 Nov;1(6):460–465. [PubMed] [Google Scholar]
  107. Schoenberg B. S., Anderson D. W., Haerer A. F. Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology. 1985 Jun;35(6):841–845. doi: 10.1212/wnl.35.6.841. [DOI] [PubMed] [Google Scholar]
  108. Schulzer M., Lee C. S., Mak E. K., Vingerhoets F. J., Calne D. B. A mathematical model of pathogenesis in idiopathic parkinsonism. Brain. 1994 Jun;117(Pt 3):509–516. doi: 10.1093/brain/117.3.509. [DOI] [PubMed] [Google Scholar]
  109. Schwartz J., Elizan T. S. Search for viral particles and virus-specific products in idiopathic Parkinson disease brain material. Ann Neurol. 1979 Sep;6(3):261–263. doi: 10.1002/ana.410060314. [DOI] [PubMed] [Google Scholar]
  110. Semchuk K. M., Love E. J., Lee R. G. Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology. 1992 Jul;42(7):1328–1335. doi: 10.1212/wnl.42.7.1328. [DOI] [PubMed] [Google Scholar]
  111. Semchuk K. M., Love E. J., Lee R. G. Parkinson's disease and exposure to rural environmental factors: a population based case-control study. Can J Neurol Sci. 1991 Aug;18(3):279–286. doi: 10.1017/s0317167100031826. [DOI] [PubMed] [Google Scholar]
  112. Semchuk K. M., Love E. J., Lee R. G. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology. 1993 Jun;43(6):1173–1180. doi: 10.1212/wnl.43.6.1173. [DOI] [PubMed] [Google Scholar]
  113. Smith C. A., Gough A. C., Leigh P. N., Summers B. A., Harding A. E., Maraganore D. M., Sturman S. G., Schapira A. H., Williams A. C., Maranganore D. M. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet. 1992 Jun 6;339(8806):1375–1377. doi: 10.1016/0140-6736(92)91196-f. [DOI] [PubMed] [Google Scholar]
  114. Smith P. R., Cooper J. M., Govan G. G., Harding A. E., Schapira A. H. Smoking and mitochondrial function: a model for environmental toxins. Q J Med. 1993 Oct;86(10):657–660. doi: 10.1093/qjmed/86.10.657. [DOI] [PubMed] [Google Scholar]
  115. Spencer P. S. Guam ALS/parkinsonism-dementia: a long-latency neurotoxic disorder caused by "slow toxin(s)" in food? Can J Neurol Sci. 1987 Aug;14(3 Suppl):347–357. doi: 10.1017/s0317167100037732. [DOI] [PubMed] [Google Scholar]
  116. Steinmetz K. A., Kushi L. H., Bostick R. M., Folsom A. R., Potter J. D. Vegetables, fruit, and colon cancer in the Iowa Women's Health Study. Am J Epidemiol. 1994 Jan 1;139(1):1–15. doi: 10.1093/oxfordjournals.aje.a116921. [DOI] [PubMed] [Google Scholar]
  117. Stephens R., Spurgeon A., Calvert I. A., Beach J., Levy L. S., Berry H., Harrington J. M. Neuropsychological effects of long-term exposure to organophosphates in sheep dip. Lancet. 1995 May 6;345(8958):1135–1139. doi: 10.1016/s0140-6736(95)90976-1. [DOI] [PubMed] [Google Scholar]
  118. Stern M. B. Head trauma as a risk factor for Parkinson's disease. Mov Disord. 1991;6(2):95–97. doi: 10.1002/mds.870060202. [DOI] [PubMed] [Google Scholar]
  119. Stern M., Dulaney E., Gruber S. B., Golbe L., Bergen M., Hurtig H., Gollomp S., Stolley P. The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients. Arch Neurol. 1991 Sep;48(9):903–907. doi: 10.1001/archneur.1991.00530210029018. [DOI] [PubMed] [Google Scholar]
  120. Steventon G. B., Heafield M. T., Waring R. H., Williams A. C. Xenobiotic metabolism in Parkinson's disease. Neurology. 1989 Jul;39(7):883–887. doi: 10.1212/wnl.39.7.883. [DOI] [PubMed] [Google Scholar]
  121. Tanner C. M. Abnormal liver enzyme-mediated metabolism in Parkinson's disease: a second look. Neurology. 1991 May;41(5 Suppl 2):89–92. doi: 10.1212/wnl.41.5_suppl_2.89. [DOI] [PubMed] [Google Scholar]
  122. Tanner C. M., Chen B., Wang W., Peng M., Liu Z., Liang X., Kao L. C., Gilley D. W., Goetz C. G., Schoenberg B. S. Environmental factors and Parkinson's disease: a case-control study in China. Neurology. 1989 May;39(5):660–664. doi: 10.1212/wnl.39.5.660. [DOI] [PubMed] [Google Scholar]
  123. Tison F., Dartigues J. F., Dubes L., Zuber M., Alperovitch A., Henry P. Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France. Acta Neurol Scand. 1994 Aug;90(2):111–115. doi: 10.1111/j.1600-0404.1994.tb02689.x. [DOI] [PubMed] [Google Scholar]
  124. Treves T. A., de Pedro-Cuesta J. Parkinsonism mortality in the US, 1. Time and space distribution. Acta Neurol Scand. 1991 Nov;84(5):389–397. doi: 10.1111/j.1600-0404.1991.tb04975.x. [DOI] [PubMed] [Google Scholar]
  125. Vanacore N., Bonifati V., Bellatreccia A., Edito F., Meco G. Mortality rates for Parkinson's disease and parkinsonism in Italy (1969-1987). Neuroepidemiology. 1992;11(2):65–73. doi: 10.1159/000110914. [DOI] [PubMed] [Google Scholar]
  126. Wang S. J., Fuh J. L., Liu C. Y., Lin K. P., Chang R., Yih J. S., Chou P., Lin K. N., Teng E. L., Larson E. B. Parkinson's disease in Kin-Hu, Kinmen: a community survey by neurologists. Neuroepidemiology. 1994;13(1-2):69–74. doi: 10.1159/000110361. [DOI] [PubMed] [Google Scholar]
  127. Wang W. Z., Fang X. H., Cheng X. M., Jiang D. H., Lin Z. J. A case-control study on the environmental risk factors of Parkinson's disease in Tianjin, China. Neuroepidemiology. 1993;12(4):209–218. doi: 10.1159/000110319. [DOI] [PubMed] [Google Scholar]
  128. Ward C. D., Duvoisin R. C., Ince S. E., Nutt J. D., Eldridge R., Calne D. B. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology. 1983 Jul;33(7):815–824. doi: 10.1212/wnl.33.7.815. [DOI] [PubMed] [Google Scholar]
  129. Weiss N. S. Should we consider a subject's knowledge of the etiologic hypothesis in the analysis of case-control studies? Am J Epidemiol. 1994 Feb 1;139(3):247–249. doi: 10.1093/oxfordjournals.aje.a116991. [DOI] [PubMed] [Google Scholar]
  130. Williams D. B., Annegers J. F., Kokmen E., O'Brien P. C., Kurland L. T. Brain injury and neurologic sequelae: a cohort study of dementia, parkinsonism, and amyotrophic lateral sclerosis. Neurology. 1991 Oct;41(10):1554–1557. doi: 10.1212/wnl.41.10.1554. [DOI] [PubMed] [Google Scholar]
  131. Wong G. F., Gray C. S., Hassanein R. S., Koller W. C. Environmental risk factors in siblings with Parkinson's disease. Arch Neurol. 1991 Mar;48(3):287–289. doi: 10.1001/archneur.1991.00530150055018. [DOI] [PubMed] [Google Scholar]
  132. Yesalis C. E., 3rd, Lemke J. H., Wallace R. B., Kohout F. J., Morris M. C. Health status of the rural elderly according to farm work history: the Iowa 65 + rural health study. Arch Environ Health. 1985 Sep-Oct;40(5):245–253. doi: 10.1080/00039896.1985.10545927. [DOI] [PubMed] [Google Scholar]
  133. Yong V. W., Perry T. L. Monoamine oxidase B, smoking, and Parkinson's disease. J Neurol Sci. 1986 Feb;72(2-3):265–272. doi: 10.1016/0022-510x(86)90014-6. [DOI] [PubMed] [Google Scholar]
  134. Zhang Z. X., Román G. C. Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidemiology. 1993;12(4):195–208. doi: 10.1159/000110318. [DOI] [PubMed] [Google Scholar]
  135. de Pedro-Cuesta J., Petersen I. J., Stawiarz L., Gudmundsson G., Gudmundsson G., Almazán J., Tulinius H., Johansson H. High levodopa use in periodically time-clustered, Icelandic birth cohorts. A vestige of parkinsonism etiology? Europarkinson Preparatory Activity Research Group. Acta Neurol Scand. 1995 Feb;91(2):79–88. doi: 10.1111/j.1600-0404.1995.tb00412.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES